News & Insights
All News & Insights
CopilotIQ and Biofourmis Merge to Create the First End-to-End Platform for AI-driven In-Home Care
CopilotIQ and Biofourmis Merge to Create the First End-to-End Platform for AI-driven In-Home Care
Merger Establishes a Category of One Company That Can Deliver In-Home Care From Pre-Surgery, to Acute, Post-Acute, and Chronic Care.
Biofourmis Unveils Digital Measure for Nocturnal Scratch and Sleep Quality in Atopic Dermatitis
Biofourmis Unveils Digital Measure for Nocturnal Scratch and Sleep Quality in Atopic Dermatitis
Biofourmis has introduced a new digital measure for assessing nocturnal scratching and sleep quality in atopic dermatitis (AD) patients. Using wearable sensors and machine-learning, this tool provides objective, continuous monitoring to support drug development and improve patient outcomes.
White paper: The Next Generation of Care-at-Home
White paper: The Next Generation of Care-at-Home
Learn why organizations like WellSpan Health and Orlando Health chose Biofourmis for care-at-home programs in our white paper.
Case Study: Wellstar MCG Health
Case Study: Wellstar MCG Health
Learn about how Wellstar MCG Health and Biofourmis' Virtual Care at Home Program reduced readmissions and ED visits while delivering hospital-quality care from the home.